UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000029288
Receipt No. R000033477
Scientific Title To evaluate the efficacy and safety of once-weekly DPP-4 inhibitor: Omarigliptin and the differences between Omarigliptin and once or twice-daily DPP-4 inhibitors for the treatment of type 2 diabetes
Date of disclosure of the study information 2017/09/29
Last modified on 2019/09/22 09:47:43

No. Disposal Last modified on Item of update
1 Insert 2017/09/25 22:57:00
2 Update 2018/09/26 22:42:50 Research ethics review
3 Update 2018/09/26 22:52:33 Recruitment status
Anticipated trial start date
Last follow-up date
4 Update 2018/09/26 22:54:48 Anticipated trial start date
5 Update 2019/03/27 14:25:56 Number of participants that the trial has enrolled
6 Update 2019/09/22 09:40:47 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email2
Email3
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/09/22 09:47:43 Date of IRB
Last follow-up date


Contact us.